|
|
|
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023) |
 |
|
12-13 June 2023
Hilton Geneva Hotel & Conference Centre, Geneva, Switzerland
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023) gathers top-level management from pharmaceutical companies of manufacturing, primary and secondary packaging, purchasing, and supply chain and procurement sectors, CMOs and CDMOs leaders, heads from government and institution on 12-13, June, 2023 in Geneva, Switzerland.
The 2-days business program of the Congress covers trends, solutions, and case-studies for the pharmaceutical industry that are presented in various formats such as panel discussions, roundtables, sessions and panels.
Among the topics are:
- Challenges and strategies for pharmaceutical business transformation in 2020-2023
- Supply chain optimisation in pharmaceuticals
- GMP requirements from regulatory guidelines
- Cost-optimization and agile pharma manufacturing
- Pharmaceutical anti-counterfeiting and brand protection
- Digital Pharma Manufacturing Revolution: Pharma 4.0
- Converting to a “batch-less” world with continuous manufacturing
The PHARMAP platform is a great place to network for future mutually beneficial partnerships. Get more information: https://sh.bgs.group/dh
|
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023)
12-13 June 2023, Hilton Geneva Hotel & Conference Centre, Geneva, Switzerland
The Pharmaceutical Manufacturing and Packaging Congress 2023 (PHARMAP 2023) gathers top-level management from pharmaceutical
companies of manufacturing, primary and secondary packaging, purchasing,
and supply chain and procurement sectors, CMOs and CDMOs leaders, heads
from government and institution on 12-13, June, 2023 in Geneva,
Switzerland.
More info >> |
|
 |
White Papers |
 |
|
 |
News and Press Releases |
 |
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
Norwich, Stevenage, UK and Laupheim, Germany, June 1, 2023 – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), and Ikarovec, which is developing novel multicistronic gene therapies to treat major ophthalmic indications, today announced that the two companies have entered into a collaboration. Under the agreement, Rentschler Biopharma’s ATMP site in Stevenage, UK, will support the bioprocess development of AAV material for planned pre-clinical testing of Ikarovec’s novel gene therapy for the treatment of geographic atrophy. This condition is an advanced form of age-related macular degeneration that can result in the progressive and irreversible destruction of retinal tissue, which can lead to loss of vision over time.
More info >> |
|
|
